Federal RuleAug 21
62
DOL Rewrites Disability Rules for 'Merit-Based Opportunity' Push
RuleLabor DepartmentFederal Contract Compliance Programs OfficeSignificant Wallet
117-hr-8289117th Congress
Banning Misleading Drug Ads Act of 2022
Sponsored By: Representative Spanberger, Abigail Davis [D-VA-7]
Unknown
Summary
Banning Misleading Drug Ads Act of 2022 This bill finalizes a 2010 proposed rule from the Food and Drug Administration (FDA) regarding television and radio prescription drug advertisements if the FDA does not otherwise issue a final rule within 180 days of the bill's enactment. (The proposed rule specifies standards for major statements about a drug's side effects in television and radio advertisements.)
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Spanberger, Abigail Davis [D-VA-7]
VA • D
Cosponsors
Rep. Wild, Susan [D-PA-7]
PA • D
Sponsored 7/5/2022
Rep. Porter, Katie [D-CA-47]
CA • D
Sponsored 7/5/2022
Rep. Craig, Angie [D-MN-2]
MN • D
Sponsored 7/5/2022
Rep. Axne, Cynthia [D-IA-3]
IA • D
Sponsored 7/5/2022
Del. Norton, Eleanor Holmes [D-DC-At Large]
DC • D
Sponsored 10/31/2022
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov